LEADER 04019nam  22006615  450 
001 9910726281503321
005 20230520150115.0
010   $a9789819921355$b(electronic bk.)
010   $z9789819921348
024 7 $a10.1007/978-981-99-2135-5
035   $a(MiAaPQ)EBC30547218
035   $a(Au-PeEL)EBL30547218
035   $a(OCoLC)1380365972
035   $a(DE-He213)978-981-99-2135-5
035   $a(BIP)089944668
035   $a(PPN)270620168
035   $a(CKB)26736417400041
035   $a(EXLCZ)9926736417400041
100   $a20230520d2023      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBiotechnology Law and Policy $eEmerging Legal Issues, Cases and Materials /$fby Alessandro Stasi
205   $a1st ed. 2023.
210  1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2023.
215   $a1 online resource (155 pages)
311 08$aPrint version: Stasi, Alessandro Biotechnology Law and Policy Singapore : Springer,c2023 9789819921348 
327   $aBackground and Overview of Biotechnology -- A Brief History of the FDA and its Role in Regulating Biotechnology Products -- Products of Biotechnology and IP System -- The Application of Patent Law to Biotechnology -- The Birth of the Biotechnology Industry -- The Limits and Challenges of Gene Editing. .
330   $aThis book covers an extensive range of issues raised by biotechnological advancements from a regulatory perspective. Written in a clear and readable style, its main objective is to give readers an idea of the relationship between biotechnology and law. Biotechnology advancements and their ethical, moral, economic, and social implications in different fields and the consequential normative demands on the law are crucial to this book. The chapters cover a multitude of themes and some of the most important legal issues arising in relation to biotechnology, including the historical development of a legal framework sufficient to protect public safety, the current biotechnology regulatory system, and the rules directing the primary agencies that regulate the products of biotechnology, namely the US Food and Drug Administration, the US Department of Agriculture, and the US Environmental Protection Agency, patents and IP rights in biotechnology, the regulation of human genome editing and its impact on health research, law and emerging genome editing technologies from recombinant DNA to CRISPR/Cas9, the development of legal principles to protect property rights in the human body and allow the efficient use of human tissue, organs, DNA, and cell-lines in medical research, and legal issues arising from the use of genetic engineered plants and animals. Presenting arguments that have been drawn from careful examination of various international documents and decisions made by legal institutions and judicial bodies, this book would be a valuable read for practitioners as well as academics of biotechnology law.
606   $aInformation technology?Law and legislation
606   $aMass media?Law and legislation
606   $aBioethics
606   $aMedical laws and legislation
606   $aBiotechnology
606   $aIT Law, Media Law, Intellectual Property
606   $aBioethics
606   $aMedical Law
606   $aBiotechnology
610   $aLaw
615  0$aInformation technology?Law and legislation.
615  0$aMass media?Law and legislation.
615  0$aBioethics.
615  0$aMedical laws and legislation.
615  0$aBiotechnology.
615 14$aIT Law, Media Law, Intellectual Property.
615 24$aBioethics.
615 24$aMedical Law.
615 24$aBiotechnology.
676   $a343.730786606
700   $aStasi$b Alessandro$0988837
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
912   $a9910726281503321
996   $aBiotechnology Law and Policy$93373745
997   $aUNINA